These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7492672)

  • 1. Effect of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in dogs with endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Apr; 57(2):385-7. PubMed ID: 7492672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the platelet-activating factor antagonist, TCV-309, and the cyclo-oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock.
    Yamanaka S; Iwao H; Yukimura T; Kim S; Miura K
    Br J Pharmacol; 1993 Dec; 110(4):1501-7. PubMed ID: 8306093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs.
    Kawamura M; Kitayoshi T; Terashita Z; Fujiwara S; Takatani M; Nishikawa K
    J Lipid Mediat Cell Signal; 1994 May; 9(3):255-65. PubMed ID: 7921785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Aug; 57(4):751-3. PubMed ID: 8519912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
    Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in reticuloendothelial function in dogs with endotoxin-induced shock.
    Okano S; Tagawa M; Hara Y; Ejima H; Motoyoshi S; Urakawa N; Furukawa K; Onda M; Ogawa R
    J Vet Med Sci; 1993 Aug; 55(4):607-11. PubMed ID: 8399741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of platelet-activating factor and prostanoids in hemodynamic changes in rat experimental endotoxic shock.
    Ebara T; Miura K; Matsuura T; Imanishi M; Yamano Y; Kim S; Iwao H
    Jpn J Pharmacol; 1996 Jul; 71(3):247-53. PubMed ID: 8854207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.
    Ogata M; Matsumoto T; Koga K; Takenaka I; Kamochi M; Sata T; Yoshida S; Shigematsu A
    Infect Immun; 1993 Feb; 61(2):699-704. PubMed ID: 8423096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock.
    Spapen H; Zhang H; Verhaeghe V; Smail N; Vincent JL
    J Crit Care; 1998 Jun; 13(2):81-90. PubMed ID: 9627275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
    Qayumi AK; English JC; Godin DV; Ansley DM; Loucks EB; Lee JU; Kim CW
    Ann Thorac Surg; 1998 Jun; 65(6):1690-7. PubMed ID: 9647083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dibutyryl cyclic AMP on hemodynamics and chemical mediators in dogs with experimentally-induced endotoxic shock.
    Okano S; Tagawa M; Urakawa N; Ogawa R
    J Vet Med Sci; 1993 Dec; 55(6):1001-4. PubMed ID: 8117795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An animal model of hyperdynamic septic shock: hemodynamic effects of injection of low doses of endotoxin in the dog].
    D'Orio V; Fossion A; Ferir A; Juchmès J; Marcelle R; Limet R
    Arch Int Physiol Biochim; 1983 Nov; 91(4):261-7. PubMed ID: 6202257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ONO-6240, a platelet-activating factor antagonist, on endotoxin shock in unanesthetized sheep.
    Toyofuku T; Kubo K; Kobayashi T; Kusama S
    Prostaglandins; 1986 Feb; 31(2):271-81. PubMed ID: 3754344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.
    Poeze M; Froon AH; Ramsay G; Buurman WA; Greve JW
    Shock; 2000 Oct; 14(4):421-8. PubMed ID: 11049104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
    Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
    Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
    Kawahara K; Tagawa T; Takahashi T; Akamine S; Nakamura A; Yamamoto S; Muraoka S; Tomita M
    Transplantation; 1993 Jun; 55(6):1438-9. PubMed ID: 8516834
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional haemodynamic effects of platelet activating factor in the rat.
    King KA; Lim SL; Pang CC
    Eur J Pharmacol; 1995 Aug; 281(2):187-93. PubMed ID: 7589206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of platelet-activating factor antagonism in posthemorrhage septic shock in pigs.
    Abu-Zidan FM; Walther S; Lennquist S
    J Trauma; 1996 Oct; 41(4):634-40. PubMed ID: 8858021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.